Back to MORGAN STANLEY MORGAN STANLEY

RXRXRXRX
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in RECURSION PHARMACEUTICALS INC

MORGAN STANLEY holds 2.7M shares of RXRX (RECURSION PHARMACEUTICALS INC), worth $10.1M as of 2026-Q2. The position was increased (+25.5% shares). RXRX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$10.1M

Current Shares

2.7M

Total Value Change

-$2.3M

Total Shares Change

+866,298

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+25.5%
$10.1M0.0%$3.67
34
2026-Q1
Decreased
2.2M
-61.4%
$6.7M0.0%$3.54
0
2025-Q4
Decreased
5.7M
-22.4%
$23.1M0.0%$4.11
0
2025-Q3
Increased
7.3M
+28.1%
$35.6M0.0%$4.91
36
2025-Q2
Increased
5.7M
+13.6%
$28.8M0.0%$5.03
33
2025-Q1
Increased
5M
+75.2%
$26.5M0.0%$5.81
43
2024-Q4
Increased
2.9M
+52.4%
$19.3M0.0%$6.77
40
2024-Q3
Increased
1.9M
+6.2%
$12.4M0.0%$6.98
30

Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used